Literature DB >> 7628468

Molecular chaperones protect against glycation-induced inactivation of glucose-6-phosphate dehydrogenase.

E Ganea1, J J Harding.   

Abstract

Glucose-6-phosphate dehydrogenase is inactivated slowly by reaction with sugars (glycation), a process thought to be important in the development of diabetic complications. A major protein from the ocular lens, alpha-crystallin. which exhibits some chaperone-like properties, protects against this inactivation. The well-known molecular chaperone GroEL (chaperonin 60 from Escherichia coli) also protects. On a molar basis, alpha-crystallin is better than GroEL at protecting against glycation-induced inactivation of glucose-6-phosphate dehydrogenase. The relative amounts of enzyme/chaperone indicate that each molecule of alpha-crystallin binds two molecules of the damaged enzyme. This supports the view that alpha-crystallin has a chaperone-like structure as well as a chaperone-like function.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7628468

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  11 in total

1.  Enzyme activity after resealing within ghost erythrocyte cells, and protection by alpha-crystallin against fructose-induced inactivation.

Authors:  Barry K Derham; John J Harding
Journal:  Biochem J       Date:  2002-12-15       Impact factor: 3.857

Review 2.  Novel roles for α-crystallins in retinal function and disease.

Authors:  Ram Kannan; Parameswaran G Sreekumar; David R Hinton
Journal:  Prog Retin Eye Res       Date:  2012-06-18       Impact factor: 21.198

3.  Glycation-induced inactivation and loss of antigenicity of catalase and superoxide dismutase.

Authors:  H Yan; J J Harding
Journal:  Biochem J       Date:  1997-12-01       Impact factor: 3.857

4.  Alphab-crystallin-assisted reactivation of glucose-6-phosphate dehydrogenase upon refolding.

Authors:  M Satish Kumar; P Yadagiri Reddy; B Sreedhar; G Bhanuprakash Reddy
Journal:  Biochem J       Date:  2005-10-15       Impact factor: 3.857

Review 5.  Can drugs or micronutrients prevent cataract?

Authors:  J J Harding
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

6.  Prion protein PrPc interacts with molecular chaperones of the Hsp60 family.

Authors:  F Edenhofer; R Rieger; M Famulok; W Wendler; S Weiss; E L Winnacker
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

7.  Identification of Mechanism-Based Inactivation in P450-Catalyzed Cyclopropanation Facilitates Engineering of Improved Enzymes.

Authors:  Hans Renata; Russell D Lewis; Michael J Sweredoski; Annie Moradian; Sonja Hess; Z Jane Wang; Frances H Arnold
Journal:  J Am Chem Soc       Date:  2016-09-14       Impact factor: 15.419

8.  The interaction of unfolding α-lactalbumin and malate dehydrogenase with the molecular chaperone αB-crystallin: a light and X-ray scattering investigation.

Authors:  Justyn W Regini; Heath Ecroyd; Sarah Meehan; Kristen Bremmell; Matthew J Clarke; Donna Lammie; Tim Wess; John A Carver
Journal:  Mol Vis       Date:  2010-11-18       Impact factor: 2.367

9.  The role of metabolism in aging.

Authors:  L S Luckinbill; P Foley
Journal:  J Am Aging Assoc       Date:  2000-04

10.  Regulation of plasma fructose and mortality in mice by the aldose reductase inhibitor lidorestat.

Authors:  Hye-Lim Noh; Yunying Hu; Tae-Sik Park; Thomas DiCioccio; Andrew J Nichols; Kazue Okajima; Shunichi Homma; Ira J Goldberg
Journal:  J Pharmacol Exp Ther       Date:  2008-10-30       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.